Jonathan Riess, MD, MS

home / authors / jonathan-riess-md-ms

Articles

The Role of Molecular Testing in Treatment Decisions for NSCLC

Todd Bauer, MD;Sandip Patel, MD;Jonathan Riess, MD, MS ;Mary Grizzard, MSN, FNP ;Kasey Bamel, NP ;Cindy Ludovico, NP

December 23rd 2024

This video segment explores the critical role of biomarker testing in identifying patients with ALK-positive NSCLC, discussing the clinical characteristics that guide the use of ALK inhibitors and addressing challenges in implementing comprehensive molecular testing in community settings.

Sarah’s Journey With ALK+ Metastatic NSCLC

Todd Bauer, MD;Sandip Patel, MD;Jonathan Riess, MD, MS ;Mary Grizzard, MSN, FNP ;Kasey Bamel, NP ;Cindy Ludovico, NP

December 23rd 2024

A panel of experts review a case of a 55-year-old mom and high school teacher who received lorlatinib for ALK+ NSCLC with brain metastases.